CH EPL (R5)
1.0.0 - trial-use Switzerland flag

CH EPL (R5), published by Federal Office of Public Health FOPH. This guide is not an authorized publication; it is the continuous build for version 1.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/bag-epl/bag-epl-fhir/ and changes regularly. See the Directory of published versions

Example RegulatedAuthorization: Reimbursement SL 17418

CH - EPL Reimbursement SL

url

FOPHDossierNumber

value: FOPH Dossier Number/17418

url

status

value: Reimbursed

url

statusDate

value: 2000-04-15

url

listingStatus

value: Listed

url

listingPeriod

value: 2000-04-15 --> (ongoing)

url

firstListingDate

value: 2000-04-15

url

costShare

value: 10

url

gamme

value: Transdermal

value: CHF32.44 (CHF)

type: Ex-factory price

changeType: Price mutation after triennal review of pharmaceuticals

changeDate: 2014-11-01

url

CH - EPL Product Price

value: CHF53.65 (CHF)

type: Retail price

changeType: VAT-change

changeDate: 2024-01-01

url

CH - EPL Product Price

subject: PackagedProductDefinition: identifier = http://fhir.ch/ig/ch-epl/sid/pcid#Clinical Product Identifier#CH-7601001029439-5470402-097; containedItemQuantity = 24 Patch; description = ESTALIS Matrixpfl 50/250 24 Stk

type: Reimbursement SL

Indications

-ExtensionReference
*ClinicalUseDefinition: type = indication

holder: Organization Sandoz Pharmaceuticals AG

Generated Narrative: Organization #holder-Sandoz-Pharmaceuticals-AG

identifier: LOC Identifier/100054743, GLN Identifier/7601001029439

name: Sandoz Pharmaceuticals AG